Back to Search
DIANE GEORGE, MD
MD
Rheumatology Physician
NPI: 1811130123IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
2012-00850(NC)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
91931(SC)2012-00850(NC)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 2003
Research & Publications (20)
Variation in chemical composition and acaricidal activity against Dermanyssus gallinae of four eucalyptus essential oils.
PMID 19089590·Exp Appl Acarol·2009
7-preclinical
Mode of action and variability in efficacy of plant essential oils showing toxicity against the poultry red mite, Dermanyssus gallinae.
PMID 19233565·Vet Parasitol·2009
7-preclinical
Testing and improving the effectiveness of trap crops for management of the diamondback moth Plutella xylostella (L.): a laboratory-based study.
PMID 19588477·Pest Manag Sci·2009
7-preclinical
Repellence of plant essential oils to Dermanyssus gallinae and toxicity to the non-target invertebrate Tenebrio molitor.
PMID 19264408·Vet Parasitol·2009
7-preclinical
The influence of 'time since last blood meal' on the toxicity of essential oils to the poultry red mite (Dermanyssus gallinae).
PMID 18565672·Vet Parasitol·2008
7-preclinical
Lack of prolonged activity of lavender essential oils as acaricides against the poultry red mite (Dermanyssusgallinae) under laboratory conditions.
PMID 18348893·Res Vet Sci·2008
7-preclinical
Introduction to 'A multitargeted approach: clinical advances in the treatment of solid tumours'.
PMID 17761717·Ann Oncol·2007
8-other
Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinoma.
PMID 17255305·Clin Cancer Res·2007
6-review
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
PMID 15756004·Clin Cancer Res·2005
4-observational
Infliximab dose and charge escalation patterns in managed care.
PMID 15198423·Manag Care Interface·2004
4-observational
Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.
PMID 14972483·Urology·2004
4-observational
The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer.
PMID 12890838·N Engl J Med·2003
8-other
Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials.
PMID 12908555·Adv Exp Med Biol·2003
6-review
Update on late relapse of germ cell tumor: a clinical and molecular analysis.
PMID 12506179·J Clin Oncol·2003
8-other
Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate.
PMID 12231066·Urology·2002
6-review
Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
PMID 11740804·Semin Oncol·2001
6-review
PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.
PMID 11319185·Cancer Epidemiol Biomarkers Prev·2001
8-other
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.
PMID 11448906·Clin Cancer Res·2001
8-other
Idiopathic sensorineural hearing disorders in adults--a pragmatic approach.
PMID 19652649·Nat Rev Rheumatol·2009
6-review
Sequence memory for prediction, inference and behaviour.
PMID 19528001·Philos Trans R Soc Lond B Biol Sci·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 16817 MARVIN RD
CHARLOTTE, NC 28277 - Phone
- (803) 913-4500
Quick Facts
- NPI
- 1811130123
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile